TNKS1BP1: A Potential Drug Target and Biomarker for Various Diseases

Target Name: TNKS1BP1

NCBI ID: G85456

TNKS1BP1

TNKS1BP1: A Potential Drug Target and Biomarker for Various Diseases

TNKS1BP1 (TAB182) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the TNK/KAP family of proteins, which are known for their role in cell signaling and inflammation.

The TNK/KAP family of proteins were identified as potential drug targets due to their involvement in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The TNK family has been shown to play a role in cell signaling and inflammation, while the KAP family is involved in the regulation of cell survival and angiogenesis.

TNKS1BP1 has been shown to be involved in several different processes in the body, including cell signaling, inflammation, and stress response. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival, as well as in the regulation of cell signaling pathways such as TGF-β and NF-kappa-B.

In addition to its role in cell signaling and inflammation, TNKS1BP1 has also been shown to be involved in the regulation of cellular processes that are important for maintaining tissue homeostasis. This includes the regulation of cell volume, cell adhesion, and cell migration, as well as the regulation of ion homeostasis and the regulation of the blood-brain barrier.

Given its involvement in a wide range of cellular processes, it is likely that TNKS1BP1 could be a valuable drug target for a variety of diseases. Studies have shown that inhibiting the activity of TNKS1BP1 has the potential to treat a variety of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, TNKS1BP1 is also a potential biomarker for several diseases. The regulation of cellular processes that are involved in the development and progression of cancer, as well as the regulation of neurodegenerative diseases, could be important targets for the diagnosis and treatment of these conditions.

The regulation of cellular processes that are involved in stress response and inflammation could also be important targets for the treatment of chronic inflammatory disorders, such as rheumatoid arthritis and inflammatory bowel disease.

Given its potential as a drug target and biomarker, TNKS1BP1 is an important target for further research into the regulation of cellular processes and the development of new treatments for a variety of diseases. Further studies are needed to fully understand the role of TNKS1BP1 in cellular processes and its potential as a drug and biomarker.

Protein Name: Tankyrase 1 Binding Protein 1

The "TNKS1BP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TNKS1BP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets